Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:In silico determination of novel SARS-CoV-2 envelope protein ion channel inhibitors
Authors:ID Kobe, Nina (Author)
ID Dreisewerd, Lennart (Author)
ID Pavlin, Matic (Author)
ID Kogovšek, Polona (Author)
ID Podlipnik, Črtomir (Author)
ID Grošelj, Uroš (Author)
ID Lukšič, Miha (Author)
Files:URL URL - Source URL, visit https://www.csbj.org/article/S2001-0370(25)00255-7/fulltext
 
.pdf PDF - Presentation file, download (1,82 MB)
MD5: 2E636090A08B5177D125256F0E5B7280
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo NIB - National Institute of Biology
Abstract:The SARS-CoV-2 envelope protein (2-EPRO), a viroporin crucial for viral pathogenesis, is a promising target for antiviral drug development as it is highly conserved and functionally important. Although it is a promising therapeutic target for the treatment of COVID-19, it has often been overlooked in previous studies. In this study, a high-throughput virtual screening of nearly one billion compounds was performed, followed by rigorous filtering and re-docking. Eight best-scoring and chemically versatile lead candidates were identified. In molecular dynamics simulations, three of these ligands showed stable protein-ligand complexes occupying the 2-EPRO channel pore. Among these, ZINC001799167680 (L3) and ZINC001081252239 (L2) exhibited the strongest binding a˙inity, with key interactions at residues ASN15, THR11 and GLU8 identified by Molecular Mechanics Poisson-Boltzmann Surface Area analysis. All ligands were compared with the known inhibitor rimantadine and showed stronger binding to the protein. These in silico results highlight the potential of focusing on the 2-EPRO ion channel in the development of novel COVID-19 therapeutics and pave the way for further in vitro and in vivo studies.
Keywords:SARS-CoV-2 envelope protein, viroporin, ion channel, channel blockers, molecular dynamics simulations, free energy calculations, drug discovery
Publication status:Published
Publication version:Version of Record
Publication date:26.06.2025
Year of publishing:2025
Number of pages:str. 2823-2831
Numbering:Vol. 27
PID:20.500.12556/DiRROS-23494 New window
UDC:577
ISSN on article:2001-0370
DOI:10.1016/j.csbj.2025.06.036 New window
COBISS.SI-ID:241440259 New window
Note:Nasl. z nasl. zaslona; Soavtorji: Lennart Dreisewerd, Matic Pavlin, Polona Kogovšek, Črtomir Podlipnik, Uroš Grošelj, Miha Lukšič; Opis vira z dne 4. 7. 2025;
Publication date in DiRROS:05.09.2025
Views:323
Downloads:129
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Computational and Structural Biotechnology Journal
Publisher:Chalmers University of Technology
ISSN:2001-0370
COBISS.SI-ID:5068826 New window

Document is financed by a project

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P2-0152-2020
Name:Kemijsko reakcijsko inženirstvo

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P4-0407-2019
Name:Okoljska in aplikativna virologija: virusi, prijatelji in sovražniki

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P2-0421-2022
Name:Trajnostne tehnologije in krožno gospodarstvo

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P1-0179-2020
Name:Napredna organska sinteza in kataliza

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P1-0201-2022
Name:Fizikalna kemija

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:I0-0022
Name:Mreža raziskovalnih infrastrukturnih centrov Univerze v Ljubljani (MRIC UL)

Funder:NIH - National Institutes of Health
Funding programme:RM1 award
Project number:RM1GM135136
Name:Solvation modeling for next-gen biomolecule simulations

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:E protein SARS-CoV-2, viroporin, ionski kanal, molekulska dinamika, odkrivanje zdravil


Back